Search

Search Constraints

You searched for: Author/Creator Berisha, Flora

Search Results

1. 2016 White Paper on recent issues in bioanalysis: focus on biomarker assay validation (BAV): (Part 3 – LBA, biomarkers and immunogenicity). (November 2016)

2. 2017 White Paper on recent issues in bioanalysis: a global perspective on immunogenicity guidelines & biomarker assay performance (Part 3 – LBA: immunogenicity, biomarkers and PK assays). (December 2017)

3. Cerebrospinal fluid neurofilament concentration reflects disease severity in frontotemporal degeneration. Issue 1 (2nd January 2014)

4. CSF biomarker variability in the Alzheimer's Association quality control program. Issue 3 (1st May 2013)

5. Divergent CSF τ alterations in two common tauopathies: Alzheimer's disease and progressive supranuclear palsy. Issue 3 (4th June 2014)

6. P1–137: Stability performance of a fully automated, chemiluminescent, beta‐amyloid 42 assay. (1st July 2013)

7. P1–167: Reproducibility of a fully automated, chemiluminescent, beta‐amyloid 42 assay. (1st July 2013)

9. P4–160: Stability performance of a fully automated, chemiluminescent tau assay for the VITROS® immunodiagnostic systems with cerebrospinal fluid over a 29‐week study. (1st July 2013)